M&A news

WAYA Acquires Nilescan and Labs

Nilescan and Labs acquired by WAYA

AcquisitionUSD19,500,000Hospitals and Health CareEG

Get the full Nilescan and Labs company profile

Access contacts, investors, buying signals & more

Open in Dashboard
Nilescan and Labs logo
Acquired

Nilescan and Labs

EgyptHospitals and Health Care

Deal value

USD19,500,000

July 21, 2026

WAYA logo
Acquirer

WAYA

WAYA has acquired Nile Scan & Labs, Egypt’s leading provider of diagnostic radiology and clinical laboratory services, for $19.5 million. This corporate acquisition marks a significant development in the regional healthcare sector. Nile Scan & Labs operates a large network of centers across Egypt, including Maadi, Dokki, Heliopolis, Sheikh Zayed, Downtown, Fifth Settlement, El-Mohandesin, and Nasr City. The company is powered by state-of-the-art technologies and prominent medical professionals, dedicated to improving patient care and ensuring accurate diagnoses.

With over 25 years of expertise, Nile Scan & Labs has served millions of patients and established itself as a partner of choice for Egypt’s leading clinicians, corporates, insurance companies, and government authorities. The acquisition by WAYA is a strategic move to integrate Nile Scan & Labs' extensive operational capabilities and market leadership. This transaction is expected to enhance WAYA's presence and offerings within the diagnostic services landscape, leveraging Nile Scan's established infrastructure and deep market penetration.

The strategic rationale behind this acquisition centers on combining WAYA's resources with Nile Scan & Labs' proven track record and advanced diagnostic services. Synergies are anticipated through the integration of Nile Scan's robust network and technological prowess, aiming to optimize service delivery and expand access to high-quality diagnostic care across Egypt. This move is poised to strengthen the combined entity's competitive position.

Looking ahead, the unified organization is expected to build upon Nile Scan & Labs' legacy of excellence and innovation. The acquisition positions the combined entity to further advance diagnostic capabilities, enhance patient experience, and drive continued growth within the dynamic healthcare market, ultimately aiming to set new standards in medical diagnostics and laboratory services.

No buying signals identified yet.

Unlock GTM signals

Discover Nilescan and Labs's tech stack and active buying intent.

View GTM signals

Unlock key decision-makers

Get direct access to the decision-makers at Nilescan and Labs.

Unlock decision-makers